SCHEMBL710062

SCHEMBL710062

OC(O)CN1CCNCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
RAD52 P43351 1/20 0.43
BAX Q07812 1/20 0.40
CHRM5 P08912 1/20 0.39
CHRM3 P20309 1/20 0.39
POLB P06746 2/20 0.39
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
IDO1 P14902 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CXCR4 P61073 1/20 0.37
SLC6A2 P23975 2/20 0.36
ATM Q13315 1/20 0.36
USP2 O75604 1/20 0.36
SLC6A4 P31645 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL28700688 0.89 SMN1; SMN2 (0.43) SMN1; SMN2RAD52BAXCHRM5CHRM3
SCHEMBL11438133 0.84 SMN1; SMN2 (0.60) SMN1; SMN2RAD52BAXCHRM5CHRM3
SCHEMBL25262548 0.84 SMN1; SMN2 (0.44) SMN1; SMN2RAD52BAXCHRM5CHRM3
SCHEMBL13890422 0.82 SMN1; SMN2 (0.42) SMN1; SMN2RAD52POLBMAPTMEN1
SCHEMBL24090587 0.82 CHRM5 (0.45) SMN1; SMN2RAD52CHRM5CHRM3HSD17B10
SCHEMBL151400 0.82 SMN1; SMN2 (0.58) SMN1; SMN2RAD52BAXCHRM5CHRM3
SCHEMBL10667505 0.80 SMN1; SMN2 (0.56) SMN1; SMN2RAD52BAXCHRM5CHRM3
SCHEMBL1974799 0.80 SMN1; SMN2 (0.56) SMN1; SMN2RAD52BAXCHRM5CHRM3
SCHEMBL6243364 0.80 SMN1; SMN2 (0.47) SMN1; SMN2RAD52BAXCHRM5CHRM3
SCHEMBL1393824 0.80 SMN1; SMN2 (0.56) SMN1; SMN2RAD52BAXCHRM5CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 449 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115646137-B Organic amine desulfurizing agent capable of effectively reducing foaming problem 北京北大先锋科技股份有限公司 2026-05-12 CN claimed
EP-4585590-A1 METHOD FOR RECOVERING HYDROXYETHYL PIPERAZINE BASF SE (DE) 2025-07-16 EP claimed
CN-118893079-A Recovery method of polyester/wool blended fabric 青岛阿脒诺材料技术有限公司 2024-11-05 CN claimed
CN-118681369-A Ternary mixed amine absorbent, preparation method thereof and application thereof in magnesite calcination flue gas treatment 辽宁信宇热能技术工程有限公司 2024-09-24 CN claimed
CN-113056458-B Production of hydroxyethyl piperazine 陶氏环球技术有限责任公司 2024-05-24 CN claimed
US-11987562-B2 Production of hydroxyethylpiperazine DOW GLOBAL TECHNOLOGIES LLC (US) 2024-05-21 US claimed
CN-115725136-B High-oxygen-index flame-retardant PP material and preparation method thereof 金发科技股份有限公司 2024-05-03 CN claimed
CN-114797469-B Organic amine desulfurization and desorption accelerator and preparation method and application thereof 双盾环境科技有限公司 2024-04-16 CN claimed
EP-3873886-B1 PRODUCTION OF HYDROXYETHYLPIPERAZINE DOW GLOBAL TECHNOLOGIES LLC (US) 2024-03-20 EP claimed
CN-117046266-A Absorbent for cooperatively capturing sulfur dioxide and carbon dioxide and method for capturing sulfur dioxide and carbon dioxide in flue gas 中国恩菲工程技术有限公司 2023-11-14 CN claimed
EP-1252151-B1 A PROCESS FOR THE PREPARATION OF QUETIAPINE AND INTERMEDIATES THEREFOR EGYT GYOGYSZERVEGYESZETI GYAR (HU) 2004-03-17 EP claimed
EP-0821664-B1 METHOD FOR PRODUCING AMINOETHYLETHANOLAMINE AND/OR HYDROXYETHYL PIPERAZINE AKZO NOBEL NV (NL) 2000-04-05 EP claimed
EP-0290862-B1 Process for the preparation of 1,4-diazabicyclo[2.2.2] octanes BASF Aktiengesellschaft (DE) 1993-06-23 EP claimed
EP-0263463-B1 Process for the preparation of 1,4-diazabicyclo[2,2,2] octanes BASF Aktiengesellschaft (DE) 1992-03-25 EP claimed
US-4837324-A Process for the reaction of piperazine, and derivatives thereof, with glyoxal, and derivatives thereof THE DOW CHEMICAL COMPANY (US) 1989-06-06 US claimed
EP-0310689-A1 Process for the preparation of 1,4-diazabicyclo(2,2,2)-octanes BASF Aktiengesellschaft (DE) 1989-04-12 EP claimed
US-4804758-A FROM HETEROCYCLIC AMINES USING BORON OR IRON SILICATE ZEOLITE CATALYSTS BASF AKTIENGESELLSCHAFT (DE) 1989-02-14 US claimed
EP-0290862-A2 Process for the preparation of 1,4-diazabicyclo[2.2.2] octanes BASF Aktiengesellschaft (DE) 1988-11-17 EP claimed
US-4757143-A Treating hydroxyethyl ethyleneamine feedstock with cyclization catalyst TEXACO INC. (US) 1988-07-12 US claimed
EP-0263463-A2 Process for the preparation of 1,4-diazabicyclo[2,2,2] octanes BASF Aktiengesellschaft (DE) 1988-04-13 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11987562-B2 Production of hydroxyethylpiperazine HAMP, HTR5A, HTR2A SMN1; SMN2 2206/4885RAD52 2017/4885BAX 4041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.